Taro Pharmaceutical Industries Ltd. (NYSE:TARO)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar modestus1 (< 20) Submitted: 5/12/2013 7:22:34 PM : Outperform Start Price: $62.58 TARO Score: +109.38

Undervalued, generics will rule

Featured Broker Partners


Advertisement